118 results
Page 4 of 6
6-K
EX-99
v4nzmd
2 Mar 15
Current report (foreign)
12:00am
6-K
EX-99
9jpyfr1umkh3jyd01yvh
6 Jan 15
BioLineRx Completes Dose Escalation Stage of
12:00am
6-K
EX-99
yexju11v7t
12 Dec 14
BioLineRx Presents Multi-Year Clinical Development
12:00am
6-K
EX-99
4h6kn3 d6
12 Dec 14
Current report (foreign)
12:00am
6-K
EX-99
spvh7c
8 Dec 14
BioLineRx Reports Positive Data from Ongoing Phase 2a
12:00am
6-K
EX-99
mvtkdb
3 Nov 14
Current report (foreign)
12:00am
6-K
EX-99
n07z66p5
17 Sep 14
Current report (foreign)
12:00am
6-K
EX-99
zd8zm3
3 Sep 14
Current report (foreign)
12:00am
6-K
EX-99
41l6f7ob
16 Jun 14
BioLineRx Receives Approval to Commence
12:00am
424B2
xe0z9t3yr a4
13 Jun 14
Prospectus for primary offering
12:00am
F-3
n8lljmztyl38w593t6p
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-99
flm30ck 4ncxlzlft5sg
20 May 14
BioLineRx Reports First Quarter 2014 Financial Results
12:00am
6-K
EX-99
ayx4q6fv 03l3h
10 Apr 14
Current report (foreign)
12:00am
6-K
EX-99
7e80y8hipx
14 Mar 14
BioLineRx Announces Issuance of United States Patent
12:00am
6-K
EX-1.1
3epl3pc bac53
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B5
2p1ng2rfeipz7uk3bnco
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
7xm4nw umfeu
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
ikqbx2dw
3 Mar 14
Current report (foreign)
12:00am